Online inquiry

IVTScrip™ mRNA-Human ANKRD12, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK16099MR)

This product GTTS-WK16099MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKRD12 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001083625.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 23253
UniProt ID Q6UB98
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD12, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK16099MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK20613MR IVTScrip™ mRNA-Human ANKRD27, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANKRD27
GTTS-WK16408MR IVTScrip™ mRNA-Human ANKRD20A4, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD20A4
GTTS-WK20633MR IVTScrip™ mRNA-Human ANKRD62, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANKRD62
GTTS-WK17942MR IVTScrip™ mRNA-Human ANKZF1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKZF1
GTTS-WK3912MR IVTScrip™ mRNA-Human CYR61, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA CYR61
GTTS-WK21567MR IVTScrip™ mRNA-Human ANXA8L1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANXA8L1
GTTS-WK24997MR IVTScrip™ mRNA-Human ARHGAP35, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP35
GTTS-WK22348MR IVTScrip™ mRNA-Human ARL6IP4, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARL6IP4
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW